4.8 Article

Cullin 3 mediates SRC-3 ubiquitination and degradation to control the retinoic acid response

出版社

NATL ACAD SCIENCES
DOI: 10.1073/pnas.1102572108

关键词

-

资金

  1. Centre National de la Recherche Scientifique
  2. Institut National de la Sante et de la Recherche Medicale
  3. Agence Nationale pour la Recherche [ANR-05-BLAN-0390-02, ANR-09-BLAN-0297-01]
  4. Association pour la Recherche sur le Cancer [ARC-07-1-3169]
  5. Fondation pour la Recherche Medicale (FRM) [DEQ20090515423]
  6. Institut National du Cancer [INCa-PL09-194, PL07-96099]
  7. Ministere de l'Enseignement Superieur et de la Recherche
  8. FRM
  9. Lady TATA Memorial Trust
  10. Agence Nationale de la Recherche (ANR) [ANR-05-BLAN-0390, ANR-09-BLAN-0297] Funding Source: Agence Nationale de la Recherche (ANR)

向作者/读者索取更多资源

SRC-3 is an important coactivator of nuclear receptors including the retinoic acid (RA) receptor a. Most of SRC-3 functions are facilitated by changes in the posttranslational code of the protein that involves mainly phosphorylation and ubiquitination. We recently reported that SRC-3 is degraded by the proteasome in response to RA. Here, by using an RNAi E3-ubiquitin ligase entry screen, we identified CUL-3 and RBX1 as components of the E3 ubiquitin ligase involved in the RA-induced ubiquitination and subsequent degradation of SRC-3. We also show that the RA-induced ubiquitination of SRC-3 depends on its prior phosphorylation at serine 860 that promotes binding of the CUL-3-based E3 ligase in the nucleus. Finally, phosphorylation, ubiquitination, and degradation of SRC-3 cooperate to control the dynamics of transcription. In all, this process participates to the anti-proliferative effect of RA.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Gastroenterology & Hepatology

Combined small molecule and loss-of-function screen uncovers estrogen receptor alpha and CAD as host factors for HDV infection and antiviral targets

Eloi R. Verrier, Amelie Weiss, Charlotte Bach, Laura Heydmann, Vincent Turon-Lagot, Arnaud Kopp, Houssein El Saghire, Emilie Crouchet, Patrick Pessaux, Thomas Garcia, Patrick Pale, Mirjam B. Zeisel, Camille Sureau, Catherine Schuster, Laurent Brino, Thomas F. Baumert

Article Biochemistry & Molecular Biology

Deubiquitylase UCHL3 regulates bi-orientation and segregation of chromosomes during mitosis

Katerina Jerabkova, Yongrong Liao, Charlotte Kleiss, Sadek Fournane, Matej Durik, Arantxa Agote-Aran, Laurent Brino, Radislav Sedlacek, Izabela Sumara

FASEB JOURNAL (2020)

Article Biology

Ral GTPases promote breast cancer metastasis by controlling biogenesis and organ targeting of exosomes

Shima Ghoroghi, Benjamin Mary, Annabel Larnicol, Nandini Asokan, Annick Klein, Nael Osmani, Ignacio Busnelli, Francois Delalande, Nicodeme Paul, Sebastien Halary, Frederic Gros, Laetitia Fouillen, Anne-Marie Haeberle, Cathy Royer, Coralie Spiegelhalter, Gwennan Andre-Gregoire, Vincent Mittelheisser, Alexandre Detappe, Kendelle Murphy, Paul Timpson, Raphael Carapito, Marcel Blot-Chabaud, Julie Gavard, Christine Carapito, Nicolas Vitale, Olivier Lefebvre, Jacky G. Goetz, Vincent Hyenne

Summary: This study identifies Ral GTPases as central molecules linking the mechanisms of EV secretion and cargo loading to their capacity to disseminate and induce pre-metastatic niches. Depletion of RalA or RalB in cells leads to limited organotropic capacities in vivo and less efficient promotion of metastasis, as well as reduced levels of the adhesion molecule MCAM/CD146 in EVs, which favors EV-mediated metastasis by targeting to the lungs. RalA, RalB, and MCAM/CD146 are factors of poor prognosis in breast cancer patients.
Article Medicine, Research & Experimental

Tenascin-C immobilizes infiltrating T lymphocytes through CXCL12 promoting breast cancer progression

Devadarssen Murdamoothoo, Zhen Sun, Alev Yilmaz, Gilles Riegel, Cherine Abou-Faycal, Claire Deligne, Ines Velazquez-Quesada, William Erne, Marine Nascimento, Matthias Morgelin, Gerard Cremel, Nicodeme Paul, Raphael Carapito, Romain Veber, Helene Dumortier, Jingping Yuan, Kim S. Midwood, Thomas Loustau, Gertraud Orend

Summary: The study found that tenascin-C inhibits CD8 T cell infiltration by inducing CXCL12, which may contribute to the low response rates of immune checkpoint therapy in cancer treatment. Blocking the CXCR4 receptor of CXCL12 enhances macrophage and CD8 T cell infiltration, reducing tumor growth and metastasis.

EMBO MOLECULAR MEDICINE (2021)

Article Oncology

Temporal multiomic modeling reveals a B-cell receptor proliferative program in chronic lymphocytic leukemia

Cedric Schleiss, Raphael Carapito, Luc-Matthieu Fornecker, Leslie Muller, Nicodeme Paul, Ouria Tahar, Angelique Pichot, Manuela Tavian, Alina Nicolae, Laurent Miguet, Laurent Mauvieux, Raoul Herbrecht, Sarah Cianferani, Jean-Noel Freund, Christine Carapito, Myriam Maumy-Bertrand, Seiamak Bahram, Frederic Bertrand, Laurent Vallat

Summary: The study reveals a proliferative genetic program activated by BCR in primary leukemic cells, consisting of 430 genes and 374 proteins. Mathematical modeling highlights a transcriptional network associated with cell proliferation.

LEUKEMIA (2021)

Article Multidisciplinary Sciences

Drug-induced phospholipidosis confounds drug repurposing for SARS-CoV-2

Tia A. Tummino, Veronica V. Rezelj, Benoit Fischer, Audrey Fischer, Matthew J. O'Meara, Blandine Monel, Thomas Vallet, Kris M. White, Ziyang Zhang, Assaf Alon, Heiko Schadt, Henry R. O'Donnell, Jiankun Lyu, Romel Rosales, Briana L. McGovern, Raveen Rathnasinghe, Sonia Jangra, Michael Schotsaert, Jean-Rene Galarneau, Nevan J. Krogan, Laszlo Urban, Kevan M. Shokat, Andrew C. Kruse, Adolfo Garcia-Sastre, Olivier Schwartz, Francesca Moretti, Marco Vignuzzi, Francois Pognan, Brian K. Shoichet

Summary: Phospholipidosis may be a shared mechanism underlying the antiviral activity of many repurposed drugs, and early detection and elimination of these effects can enable a focus on molecules with therapeutic potential.

SCIENCE (2021)

Article Multidisciplinary Sciences

Oncolytic H-1 parvovirus binds to sialic acid on laminins for cell attachment and entry

Amit Kulkarni, Tiago Ferreira, Clemens Bretscher, Annabel Grewenig, Nazim El-Andaloussi, Serena Bonifati, Tiina Marttila, Valerie Palissot, Jubayer A. Hossain, Francisco Azuaje, Hrvoje Miletic, Lars A. R. Ystaas, Anna Golebiewska, Simone P. Niclou, Ralf Roeth, Beate Niesler, Amelie Weiss, Laurent Brino, Antonio Marchini

Summary: In-depth understanding of the life cycle of H-1 parvovirus (H-1PV) is crucial for the rational design of combination strategies and development of more effective viruses. The identification of laminin gamma 1 (LAMC1) as a crucial modulator of H-1PV infection highlights the importance of laminin family members in cell attachment and entry. Elevated levels of LAMC1 are found to correlate with increased H-1PV oncolytic activity in various cancer cell lines.

NATURE COMMUNICATIONS (2021)

Article Multidisciplinary Sciences

Impairing flow-mediated endothelial remodeling reduces extravasation of tumor cells

Gautier Follain, Nael Osmani, Valentin Gensbittel, Nandini Asokan, Annabel Larnicol, Luc Mercier, Maria Jesus Garcia-Leon, Ignacio Busnelli, Angelique Pichot, Nicodeme Paul, Raphael Carapito, Seiamak Bahram, Olivier Lefebvre, Jacky G. Goetz

Summary: The study found that blood flow characteristics are conducive to blocking tumor cell penetration and validated the importance of VEGFR in endothelial remodeling and subsequent tumor cell metastasis.

SCIENTIFIC REPORTS (2021)

Article Immunology

Impact of Tenascin-C on Radiotherapy in a Novel Syngeneic Oral Squamous Cell Carcinoma Model With Spontaneous Dissemination to the Lymph Nodes

Caroline Spenle, Thomas Loustau, Helene Burckel, Gilles Riegel, Cherine Abou Faycal, Chengbei Li, Alev Yilmaz, Luciana Petti, Fanny Steinbach, Constance Ahowesso, Camille Jost, Nicodeme Paul, Raphael Carapito, Georges Noel, Fabienne Anjuere, Nathalie Salome, Gertraud Orend

Summary: The study using a novel syngeneic tongue OSCC grafting model found high TNC expression and TIL infiltration in irradiated tumors, while TNC knockout host showed less immune suppressive TME and tendency towards more tumor regression, which could be significant for future anti-cancer targeting of OSCC.

FRONTIERS IN IMMUNOLOGY (2021)

Article Medicine, Research & Experimental

Evaluation of two in vitro assays for tumorigenicity assessment of CRISPR-Cas9 genome-edited cells

Myriam Lemmens, Benoit Fischer, Michael Zogg, Lindsey Rodrigues, Grainne Kerr, Alberto del Rio-Espinola, Fanny Schaeffer, Danilo Maddalo, Valerie Dubost, Alessandro Piaia, Arne Mueller, Ulla Plappert-Helbig, Ulrike Naumann, Jasmin Haegele, Alex Odermatt, Hans-Joerg Martus, Silvana Libertini

Summary: Off-target editing is a safety concern in CRISPR-Cas9 gene therapy, and two in vitro assays, SACF and GILA, provide sensitive and valid methods for evaluating tumorigenicity of genome-edited cells.

MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2021)

Article Immunology

Distinct antibody profiles in HLA-B*57+, HLA-B*57- HIV controllers and chronic progressors

Jeromine Klingler, Nicodeme Paul, Geraldine Laumond, Sylvie Schmidt, Luzia M. Mayr, Thomas Decoville, Olivier Lambotte, Brigitte Autran, Seiamak Bahram, Christiane Moog

Summary: The study found that HIV-1 controllers have a unique HIV-specific antibody profile that may contribute to the control of HIV replication. This emphasizes the importance of analyzing multifunctional antibody responses in vaccine research.
Article Cell Biology

Identification of driver genes for critical forms of COVID-19 in a deeply phenotyped young patient cohort

Raphael Carapito, Richard Li, Julie Helms, Christine Carapito, Sharvari Gujja, Veronique Rolli, Raony Guimaraes, Jose Malagon-Lopez, Perrine Spinnhirny, Alexandre Lederle, Razieh Mohseninia, Aurelie Hirschler, Leslie Muller, Paul Bastard, Adrian Gervais, Qian Zhang, Francois Danion, Yvon Ruch, Maleka Schenck, Olivier Collange, Thien-Nga Chamaraux-Tran, Anne Molitor, Angelique Pichot, Alice Bernard, Ouria Tahar, Sabrina Bibi-Triki, Haiguo Wu, Nicodeme Paul, Sylvain Mayeur, Annabel Larnicol, Geraldine Laumond, Julia Frappier, Sylvie Schmidt, Antoine Hanauer, Cecile Macquin, Tristan Stemmelen, Michael Simons, Xavier Mariette, Olivier Hermine, Samira Fafi-Kremer, Bernard Goichot, Bernard Drenou, Khaldoun Kuteifan, Julien Pottecher, Paul-Michel Mertes, Shweta Kailasan, M. Javad Aman, Elisa Pin, Peter Nilsson, Anne Thomas, Alain Viari, Damien Sanlaville, Francis Schneider, Jean Sibilia, Pierre-Louis Tharaux, Jean-Laurent Casanova, Yves Hansmann, Daniel Lidar, Mirjana Radosavljevic, Jeffrey R. Gulcher, Ferhat Meziani, Christiane Moog, Thomas W. Chittenden, Seiamak Bahram

Summary: In this study, multi-omics analysis and artificial intelligence were used to examine the differences in biological factors between critical and non-critical COVID-19 patients in a young and otherwise healthy cohort. The study identified ADAM9 as a driver of disease severity and a potential therapeutic target.

SCIENCE TRANSLATIONAL MEDICINE (2022)

Article Cell & Tissue Engineering

High-content phenotyping of Parkinson's disease patient stem cell-derived midbrain dopaminergic neurons using machine learning classification

Aurore Vuidel, Loic Cousin, Beatrice Weykopf, Simone Haupt, Zahra Hanifehlou, Nicolas Wiest-Daessle, Michaela Segschneider, Joohyun Lee, Yong-Jun Kwon, Michael Peitz, Arnaud Ogier, Laurent Brino, Oliver Bruestle, Peter Sommer, Johannes H. Wilbertz

Summary: Combining multiple cellular phenotypes can improve the accuracy of midbrain dopaminergic neuron models for Parkinson's disease. Machine learning classification can detect chemical compound treatments related to LRRK2.

STEM CELL REPORTS (2022)

Article Pathology

Loss of Hepatic Leucine-Rich Repeat- Containing G-Protein Coupled Receptors 4 and 5 Promotes Nonalcoholic Fatty Liver Disease

Enrica Saponara, Carlos Penno, Vanessa Orsini, Zhong-Yi Wang, Audrey Fischer, Alexandra Aebi, Meztli L. Matadamas-Guzman, Virginie Brun, Benoit Fischer, Margaret Brousseau, Peter O'Donnell, Jonathan Turner, Alexandra Graff Meyer, Laura Bollepalli, Giovanni dArio, Guglielmo Roma, Walter Carbone, Stefano Annunziato, Michael Obrecht, Nicolau Beckmann, Chandra Saravanan, Arnaud Osmont, Philipp Tropberger, Shola M. Richards, Christel Genoud, Svenja Ley, Iwona Ksiazek, Florian Nigsch, Luigi M. Terracciano, Heiko S. Schadt, Tewis Bouwmeester, Jan S. Tchorz, Heinz Ruffner

Summary: This study investigated the role of Lgr4/5 in nonalcoholic fatty liver disease (NAFLD) and found that the loss of Lgr4/5 in hepatic epithelial cells led to hepatic steatosis and fibrosis in mice fed with a high-fat diet. The study also demonstrated that the loss of Lgr4/5 resulted in impaired bile acid secretion, altered lipid homeostasis, and deregulation of lipoprotein pathways, all of which contributed to the onset of NAFLD.

AMERICAN JOURNAL OF PATHOLOGY (2023)

Article Gastroenterology & Hepatology

Cell-based cccDNA reporter assay combined with functional genomics identifies YBX1 as HBV cccDNA host factor and antiviral candidate target

Eloi R. Verrier, Gaetan Ligat, Laura Heydmann, Katharina Doernbrack, Julija Miller, Anne Maglott-Roth, Frank Juehling, Houssein El Saghire, Margaux J. Heuschkel, Naoto Fujiwara, Sen-Yung Hsieh, Yujin Hoshida, David E. Root, Emanuele Felli, Patrick Pessaux, Atish Mukherji, Laurent Mailly, Catherine Schuster, Laurent Brino, Michael Nassal, Thomas F. Baumert

Summary: Chronic hepatitis B virus (HBV) infection is a major cause of liver disease and hepatocellular carcinoma. The covalently closed circular (ccc) DNA, which is not targeted by current treatments, is crucial for viral cure. This study established a cell-based HBV cccDNA reporter assay and identified Y box binding protein 1 (YBX1) as an important host factor in the early steps of HBV life cycle. The expression of YBX1 in patients also correlates with HBV load and liver disease progression.
暂无数据